Sarah Ikenberry
Senior Communications Advisor, Food and Drug Administration, Center for Evaluation and Research
Sarah Ikenberry is a Senior Communication Advisor for the Office of Therapeutic Biologics and Biosimilars (OTBB) in the Food and Drug Administration’s (FDA) Center for Evaluation and Research (CDER) where she provides communication advice and support to senior leaders and the agency about communicating strategic priorities, initiatives, and information about biosimilar and interchangeable products. She also manages stakeholder education and outreach activities for OTBB. Sarah has a Master of Arts in Communication from Johns Hopkins University.
